Approximately 5.5 million bottles of Prevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, have been recalled. This over-the-counter heartburn medication was manufactured by GlaxoSmithKline Nebraska and distributed in 14-count bottles packaged in one, two, or three-bottle cartons. The recall was initiated due to deviations from current Good Manufacturing Practice (CGMP) standards, which are the regulations required by the FDA to ensure pharmaceutical quality and safety. Consumers who have these products should check their lot numbers and expiration dates immediately and consult with a healthcare provider regarding continued use.
Manufacturing deviations mean the product may not have been produced under the strict quality control standards required to ensure its safety, purity, and effectiveness. While no specific injuries or adverse reactions were reported in the data, failing to follow these manufacturing protocols can lead to inconsistent drug quality or potential contamination.
Contact healthcare provider or pharmacist
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.